全部分类
  • ZJ 43
ZJ 43的可视化放大

ZJ 43

ZJ 43 是一种有效的 NAAG 肽酶抑制剂,IC50 为 2.4 nM,Ki 为 0.8 nM。

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

ZJ 43的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 10mg
    ¥6912.00
    5530.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajci20372
  • CAS: 723331-20-2
  • 别名:
  • 分子式: C12H20N2O7
  • 分子量: 304.3
  • 纯度: >98%
  • 溶解度: <30.43mg/ml in Water; <30.43mg/ml in DMSO
  • 储存: Store at -20°C
  • 库存: 现货

Background

IC50: 2.4 nM


ZJ-43 is a N-acetylaspartylglutamate (NAAG) peptidase inhibitor.


The peptide neurotransmitter N-acetylaspartylglutamate (NAAG) is reported to act as an agonist at group II metabotropic glutamate receptors. NAAG is inactivated by extracellular peptidase activity leading to yielding glutamate and N-acetylaspartate.


In vitro: As a potent inhibitor of glutamate carboxypeptidase II and III (GCP II and III) with Kivalues of 0.8 and 23 nM respectively, ZJ-43 inhibited the hydrolysis of NAAG via indirect interactions with NMDA or metabotropic glutamate receptors [1].


In vivo: Intravenous injection of ZJ-43 coiuld suppress both phases of the agitation behaviour induced by paw formalin injection in the rat neuropathic pain model. Moreover, intravenous administration of ZJ-43 attenuated the level of mechanical allodynia induced by the nerve ligation. These effects of ZJ-43 in both the formalin test and the partial sciatic nerve ligation model were completely antagonized by pretreatment with LY-341495, which was a highly selective group II mGluR antagonist [1].


Clinical trial: N/A

Reference:
[1] Yamamoto T1,Hirasawa S,Wroblewska B,Grajkowska E,Zhou J,Kozikowski A,Wroblewski J,Neale JH.? Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur J Neurosci.2004 Jul;20(2):483-94.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算